Shire Wins Glaxo’s Muscle in Bid to Kickstart Vyvanse Sales (Bloomberg)
Tuesday, March 31st, 2009
March 31 (Bloomberg) -- Shire Plc gained GlaxoSmithKline Plc’s marketing power to spur sales of the Vyvanse attention- deficit drug for adults as its predecessor, Adderall, loses patent protection.